Stop relying on generic claims and use operational consulting to transform your software firm into a strategic partner for ...
Stop funding your marketing alone and start using the co-marketing budgets available through your channel ecosystem.
DevPro Biopharma, Bespak complete early feasibility studies for new groundbreaking albuterol inhaler
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
Miami, FL, and Basking Ridge, NJ , March 23, 2021 (GLOBE NEWSWIRE) -- The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma LLC, a clinical research and development company, ...
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results